• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB cases, SPCs, clinical trials, drug

STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB cases, SPCs, clinical trials, drug

Paperback

Series: Drugpatentwatch Business Intelligence Reports

Medical Reference

Currently unavailable to order

ISBN13: 9798310059221
Publisher: Independently Published
Pages: 272
Weight: 1.40
Height: 0.57 Width: 8.50 Depth: 11.00
Language: English

STIVARGA Drug Profile, 2025 is part of DrugPatentWatch's deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Also in

Medical Reference